Robert Soliva took his BSc in Molecular Biology and Biochemistry at the University of Barcelona (UB), finishing his studies in the UK.
Later, he took his PhD in computational chemistry in the group of Dr. Modesto Orozco (UB/ IRB-Institute of Research in Biomedicine). He worked in the Drug Discovery unit of Laboratorios Uriach/Palau Pharma for 11 years, during which he actively contributed to the development of several clinical candidates. Afterwards, he worked during 6 years at the IP law firm ZBM Patents&Trademarks.
In 2016 co-founded the company Nostrum Biodiscovery, the first spin off of the BSC (Barcelona Supercomputing Center) and IRB, where he first acted as CSO and then CSO/CEO. Later, he took charge of the Discovery team at Oryzon Genomics.
He is currently Principal Data Scientist at Almirall.
